# Zentalis Pharmaceuticals, Inc. (ZNTL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ZNTL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -112.99M | $ -103.22M | $ 37.69M | $ 143.65M |
| 2025 | $ 0 | $ -140.34M | $ -128.24M | $ 39.58M | $ 216.20M |
| 2024 | $ 70.87M | $ -174.31M | $ -179.82M | $ 42.65M | $ 337.19M |
| 2023 | $ 0 | $ -315.93M | $ -225.34M | $ 45.77M | $ 437.28M |
| 2022 | $ 0 | $ -264.54M | $ -185.77M | $ 47.33M | $ 433.80M |
| 2021 | $ 0 | $ -188.67M | $ -190.42M | $ 45.91M | $ 363.95M |
| 2020 | $ 0 | $ -150.12M | $ -111.57M | $ 2.00M | $ 308.58M |
| 2019 | $ 0 | $ -58.94M | $ -50.98M | $ 2.48M | $ 61.60M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.26 |
| Liabilities / Eq | 0.50 |
| Current Ratio | 4.82 |

## Other views

- [Metrics](https://sponda.capital/en/ZNTL.md)
- [Charts](https://sponda.capital/en/ZNTL/charts.md)
- [Compare](https://sponda.capital/en/ZNTL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.